Recent HbA1C value-Above 7 Posts on Medivizor
Navigation Menu

Recent HbA1C value-Above 7 Posts on Medivizor

Could daily insulin injections be replaced by weekly injections in patients with type 2 diabetes?

Could daily insulin injections be replaced by weekly injections in patients with type 2 diabetes?

Posted by on Oct 11, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the treatment of type 2 diabetes with either daily or weekly insulin injections. They found that weekly insulin was as safe and effective as daily injections. Some background Glycated hemoglobin (Hba1c) is a measurement of how well a person’s blood sugars are controlled over a 3 month period. This is...

Read More

Looking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes

Looking for participants to trial the impact of tailored meals and nutrition education for uncontrolled diabetes

Posted by on Aug 23, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study is evaluating the effect of medically tailored meals and nutrition education via tele-health for patients with uncontrolled type 2 diabetes (T2D). The outcomes include changes in blood glucose control, body weight, and confidence in self-managing care. This study is taking place in Philadelphia, Pennsylvania, United...

Read More

Can insulin glargine 300 reduce hypoglycemia risk?

Can insulin glargine 300 reduce hypoglycemia risk?

Posted by on Aug 20, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared patients with type 2 diabetes (T2D) switching to either insulin glargine 300 (Toujeo) or insulin glargine 100 (Lantus). It found that both types of insulin glargine improved blood glucose control, and insulin glargine 300 had a lower risk of hypoglycemia (dangerously low blood glucose levels) outside of a clinical...

Read More

Is dulaglutide more effective than insulin glargine for patients with type 2 diabetes?

Posted by on Apr 7, 2020 in Diabetes mellitus | 0 comments

In a nutshell This article looked at the effectiveness of dulaglutide (Trulicity) compared to insulin glargine (Lantus) for patients with uncontrolled type 2 diabetes (T2D). This study concluded that dulaglutide is more effective for these patients compared to insulin glargine. Some background Metformin is recommended as a first-line treatment for...

Read More

Evaluating a combination therapy for the treatment of type 2 diabetes

Posted by on Jan 30, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the safety and effectiveness of a combination treatment between sodium-glucose cotransporter 2 (SGLT) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists for patients with Type 2 diabetes (T2D). This study concluded that combination treatment improved blood glucose control and reduced weight loss for...

Read More

Evaluating combination therapy versus metformin only for patients with Type 2 diabetes

Posted by on Nov 13, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated whether adding vildagliptin (Galvus) to metformin (Glucophage) could improve the duration of blood glucose control for patients with newly diagnosed Type 2 Diabetes (T2D). The authors found that this treatment combination improved long-term blood glucose control for these patients. Some background...

Read More

Evaluating oral semaglutide compared to liraglutide injection in patients with type 2 diabetes

Posted by on Oct 5, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared the safety and effectiveness of oral semaglutide with liraglutide administered via subcutaneous (under the skin) injection in patients with type 2 diabetes (T2D). The authors concluded that both treatments were similarly safe and effective in these patients. Some background Glucagon-like-peptide-1 (GLP1)...

Read More

Long-term outcomes of pioglitazone plus insulin in patients with type 2 diabetes

Posted by on Oct 5, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the impact of long-term pioglitazone (Actos) treatment on outcomes for patients with type 2 diabetes (T2D) taking insulin. The authors concluded that this treatment lowered mortality risk for these patients. Some background As T2D progresses, more intensive treatment may be required. Typically, this means increasing...

Read More

Looking for patients with poorly controlled type 2 diabetes to try the EndoBarrier System

Posted by on Sep 30, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study is investigating the safety and effectiveness of the EndoBarrier system for patients with poorly controlled type 2 diabetes (T2D) and obesity. The main outcome to be measured will be the change in blood glucose levels. This trial is recruiting in multiple locations across the United States. The details Bariatric surgery is the...

Read More

Is IDegLira more effective than degludec or liraglutide alone for treating uncontrolled Type 2 diabetes?

Posted by on Sep 16, 2019 in Diabetes mellitus | 0 comments

In a nutshell This study compared IDegLira (Xultophy) to insulin degludec (Tresiba) or liraglutide (Victoza) alone in patients with uncontrolled Type 2 diabetes (T2D). The authors concluded that combined IDegLira was more effective and had fewer side effects than either insulin medication alone. Some background One of the main...

Read More